Roivant President & CIO Sells Over $34 Million in Shares
ROIV has more than doubled off its 52-week low of $10.705.
Summary
Roivant Sciences' President and CIO, Mayukh Sukhatme, sold over $34 million worth of common shares in an open market transaction, following the exercise of stock options.
Key Events · Ownership and Investor Activity · ROIV
-
Insider Sale
President and CIO Mayukh Sukhatme sold 1,000,000 shares for a total of $34,105,000 in open market transactions.
-
Option Exercise Preceding Sale
The sale followed the exercise of 1,000,000 stock options at a cost of $3,850,000.
-
Key Executive Disposition Near Highs
This significant open market sale by a top executive occurred while the stock is trading near its 52-week high, adding to a recent pattern of insider distribution.
Analysis · ROIV · Life Sciences
Mayukh Sukhatme, President and CIO, executed a significant sale of company stock, disposing of over $34 million in shares. This transaction, occurring near the company's 52-week high, represents a notable reduction in direct holdings by a key executive. While the sale followed an option exercise, the substantial open market disposition by a top insider can be interpreted as a lack of conviction at current price levels.
How filings like this one have moved
In the 30 days to Nov 17, 2026, 38% of the 3791 measured filings Wiseek scored 7 moved their stock by 5% or more by the next session's close. The median move was 0.00%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, ROIV was trading at $34.74 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $25B. The 52-week trading range was $10.71 to $34.83. This filing was assessed with negative market sentiment and an importance score of 7 out of 10.